Mog001 50553 — Washington D.C., District of Columbia

Mog001 50553 is a clinical research site located in Washington D.C., District of Columbia, United States 20057.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Mog001 50553 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD).

Sponsors: UCB Biopharma SRL.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mog001 50553?

Mog001 50553 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mog001 50553 conducted?

Mog001 50553 has 1 clinical trials on record, with 1 currently active. Their work covers Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOG-AD).

Is Mog001 50553 accredited by Crixeo Health?

Mog001 50553 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mog001 50553?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.